Danazol for benign breast disease
Non-randomised trial
OA: closed
CC0
⤵ 7 in-corpus citations
AI-generated summary
This paper reviews studies on the use of danazol to treat benign breast disease, examining its efficacy and side effects.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Three groups of women with benign breast disease were treated with danazol for 3 to 6 months. Doses of 100 mg per day were given to 40 patients, 200 mg to 55, and 400 mg to 35. The age range of the patients was 20 to 48 years. The patients were rechecked at 6-month intervals over a period of 48 months. Most of them were seen four or more times after completion of therapy. Elimination of nodularity occurred in about two thirds; three experienced no improvement, and partial resolution was obtained in the remainder. Untoward effects were minimal or trivial. Danazol proved to be an excellent hormonal agent in the management of fibrocystic disease of the breast.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (20)
- Clinical studies with an antigonadotropin-Danazol via openalex
- Danazol binding and translocation of steroid receptors via openalex
- Danazol increasingly used. via openalex
- Danazol Inhibits Steroidogenesis via openalex
- Danazol in the treatment of benign breast disease via openalex
- Danazol therapy in hormone-sensitive mammary carcinoma via openalex
- Effects of danazol on gonadotropin levels in castrated rhesus monkeys via openalex
- Studies on the treatment of gynaecomastia with danazol (Danol). via openalex
- The effect of danazol in the treatment of chronic cystic mastitis via openalex
- The use of an impeded androgen--danazol--in the management of benign breast disorders via openalex
- Treatment of benign breast disease with danazol: a follow-up report via openalex
- Treatment of severe cyclical mastalgia via openalex
- doi:10.1016/0002-9610(62)90147-2 via openalex
- doi:10.1056/nejm198303243081214 via openalex
- W6608116475 via openalex
- W6716130330 via openalex
- W6719018724 via openalex
- doi:10.1177/030006057700500207 via openalex
- doi:10.1016/b978-0-12-571126-5.50013-3 via openalex
- doi:10.1016/s0015-0282(16)43953-1 via openalex
Cited by (6)
- A Comparative Study of Danazol alone with Danazol Combined with Evening Primrose Oil in the Treatment of Fibrocystic Breast Disease 2022
- Office gynecology for the primary care physician, part II: pelvic pain, vulvar disease, disorders of menstruation, premenstrual syndrome, and breast disease 1996
- Danazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up--the Hjørring project 1984
- Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease 1982
- Fibrocytic breast disease: current status of diagnosis and treatment 1982
- The treatment of benign breast disease with danazol 1980
Source provenance
- openalex
- last seen: 2026-05-11T04:00:27.769720+00:00
- pubmed
- last seen: 2026-10-08T21:58:42.677500+00:00
- unpaywall
- last seen: 2026-10-20T06:27:24.728081+00:00
License: CC0
· commercial use OK